Levelanz

Levetiracetam, the active ingredient in Levelanz, is a antiepileptic presented as an oral tablet for oral use. It is prescribed to manage various seizure types in patients requiring seizure control. GNH USA supplies Levelanz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug that acts on neuronal excitability to control seizure activity.

Partial-onset seizures: Reduces frequency and severity of focal seizures. Generalized tonic-clonic seizures: Helps prevent convulsive seizure episodes. Myoclonic seizures: Controls sudden, brief muscle jerks associated with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Drowsiness: Feeling unusually sleepy or fatigued. - Dizziness: Light‑headed sensation or loss of balance. - Headache: Mild to moderate head pain. - Irritability: Mood changes or increased agitation. - Nausea: Stomach discomfort or urge to vomit. - Nasal congestion: Stuffy or blocked nose.

Serious or Rare Side Effects: - Severe allergic reaction: Rash, swelling, or difficulty breathing. - Mood disorders: Depression or suicidal thoughts. - Blood disorders: Unusual bruising or bleeding. - Liver dysfunction: Jaundice or elevated liver enzymes. - Severe skin reactions: Stevens‑Johnson syndrome. - Multi‑organ involvement: Rare systemic autoimmune reactions.

Before using Levelanz, consider the following safety measures.

Pregnancy: Discuss risks and benefits with a healthcare professional. Renal impairment: Dose adjustment may be required in reduced kidney function. Concomitant CNS depressants: Monitor for enhanced sedation. History of psychiatric disorders: Observe for mood changes. Drug‑induced rash: Discontinue if severe skin reactions occur. Store at ambient temperature: Keep below 25°C, in original packaging, protected from moisture.

Levetiracetam can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: May reduce levetiracetam plasma levels. - Phenobarbital: Potential decrease in seizure control.

Moderate Interactions (Monitor Closely): - Alcohol: Increases CNS depression risk. - Sedative antihistamines: May enhance drowsiness. - Other antiepileptics: Adjust dosing based on therapeutic response. - Hormonal contraceptives: Possible reduced effectiveness. - CYP enzyme inducers: May affect drug metabolism.